Healthcare provider profile · identity verified

Laurence Williams, MD

Internal Medicine · AURORA, CO · NPI 1235197880

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	258	81
Amlodipine Besylate	Amlodipine Besylate	215	68
Omeprazole	Omeprazole	185	57
Losartan Potassium	Losartan Potassium	162	47
Lisinopril	Lisinopril	143	42
Oxycodone Hcl	Oxycodone Hcl	132	21
Gabapentin	Gabapentin	129	34
Levothyroxine Sodium	Levothyroxine Sodium	100	32
Metformin Hcl	Metformin Hcl	98	28
Simvastatin	Simvastatin	89	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	76	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	18
Allopurinol	Allopurinol	69	17
Hydrochlorothiazide	Hydrochlorothiazide	69	21
Metoprolol Tartrate	Metoprolol Tartrate	64	17
Trazodone Hcl	Trazodone Hcl	61	21
Albuterol Sulfate Hfa	Albuterol Sulfate	60	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	11
Potassium Chloride	Potassium Chloride	53	17
Rosuvastatin Calcium	Rosuvastatin Calcium	53	18
Fluticasone Propionate	Fluticasone Propionate	52	24
Tamsulosin Hcl	Tamsulosin Hcl	49	14
Alendronate Sodium	Alendronate Sodium	47	13
Sertraline Hcl	Sertraline Hcl	46	13
Trulicity	Dulaglutide	45	suppressed
Eliquis	Apixaban	40	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	40	13
Olmesartan Medoxomil	Olmesartan Medoxomil	36	12
Ketoconazole	Ketoconazole	35	suppressed
Spironolactone	Spironolactone	34	suppressed
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Celecoxib	Celecoxib	31	12
Ozempic	Semaglutide	31	11
Furosemide	Furosemide	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Metoprolol Succinate	Metoprolol Succinate	27	suppressed
Famotidine	Famotidine	26	suppressed
Morphine Sulfate Er	Morphine Sulfate	26	suppressed
Telmisartan	Telmisartan	26	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Topiramate	Topiramate	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	15
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Finasteride	Finasteride	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	13
Pantoprazole Sodium	Pantoprazole Sodium	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Prednisone	Prednisone	20	12
Colchicine	Colchicine	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Montelukast Sodium	Montelukast Sodium	15	suppressed
Valsartan	Valsartan	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Carvedilol	Carvedilol	13	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Desonide	Desonide	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Procto-Med Hc	Hydrocortisone	12	suppressed
Fluconazole	Fluconazole	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Ritalin La	Methylphenidate Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error